IPOGrid
0001409269
IPO filing research

Venus Concept Inc.

Surgical & Medical Instruments & Apparatus · VERO

follow-on effective Nasdaq Capital Market EFFECT

Venus Concept Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2026-02-10. Current deal snapshot: exchange Nasdaq Capital Market.

Filing Timeline

SEC EDGAR
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000509
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000507
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000505
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000504
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000503
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000502
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000501
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000500
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000499
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000498
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000497
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2026-02-10 · 9999999995-26-000496
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2025-07-28 · 9999999995-25-002372
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-07-24 · 0001140361-25-027108
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2025-06-20 · 0001140361-25-023212
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
2025-06-09 · 0001140361-25-021861
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
Price $4.06 · 386,700 shares · Gross proceeds $1,570,002
Common Stock · Exchange Nasdaq Capital Market · Ticker VERO · Use of proceeds Proceeds will be used for general corporate purposes. · Underwriters H.C. Wainwright & Co., LLC
2025-04-14 · 0001140361-25-013577
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows S-4 and confirms the priced prospectus.
2025-04-10 · 0001140361-25-013191
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-11-01 · 9999999995-24-003347
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-04-25 · 9999999995-24-001126
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2024-04-17 · 9999999995-24-001010
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2024-04-03 · 0001140361-24-017610
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
Price $1.47 · 817,748 shares · Gross proceeds $1,198,001
Common Stock · Exchange Nasdaq Capital Market · Ticker VERO · Private placement warrants to purchase 817,748 shares at $1.34 per share · Use of proceeds Working capital · Underwriters H.C. Wainwright & Co., LLC
2024-02-27 · 0001140361-24-009627
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-12-20 · 9999999995-23-003697
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-12-20 · 9999999995-23-003694
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-12-23 · 9999999995-22-003640
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
Gross proceeds $11,000,000
Common Stock · Exchange Nasdaq · Ticker VERO · Use of proceeds General corporate purposes · Underwriters Lincoln Park Capital Fund, LLC
2022-07-12 · 0001140361-22-025844
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-01-24 · 9999999995-22-000209
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-10-25 · 9999999995-21-004023
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-02-08 · 9999999995-21-000507
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
Price $2.00 · 11,250,000 shares · Gross proceeds $22,500,000
Common Stock · Exchange Nasdaq Global Market · Ticker VERO · Each share is sold with one-half of a Warrant · Warrants to purchase up to 5,625,000 shares at $2.50 per share exercisable for 5 years · Flags units, warrants · Underwriters Oppenheimer & Co., Ladenburg Thalmann
2020-12-23 · 0001193125-20-325135
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
2020-12-21 · 0001193125-20-323152
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
Gross proceeds $31,000,000
common stock · Exchange Nasdaq Global Market · Ticker VERO · Underwriters Lincoln Park Capital Fund, LLC
2020-06-16 · 0001193125-20-170498
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-14 · 9999999995-20-001158
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-02-12 · 9999999995-20-000338
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2019-10-31 · 0001193125-19-280584
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2019-09-27 · 0001193125-19-257657
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2019-09-10 · 9999999995-19-002046
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2019-09-10 · 0001193125-19-242176
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B4 and confirms the priced prospectus.
2019-09-10 · 0001193125-19-242173
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior EFFECT filing.
261,637,146 shares
Common Stock · Exchange Nasdaq Global Market · Ticker HAIR · Use of proceeds No issuer proceeds; securities issued in exchange for Venus Concept shares · Flags foreign_private_issuer
2019-09-09 · 0001193125-19-241105
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior EFFECT filing.
261,637,146 shares
Common stock, $0.0001 par value per share of Restoration Robotics, Inc. · Exchange Nasdaq Global Market · Ticker HAIR · Use of proceeds Merger and related transactions
2019-08-23 · 0001193125-19-227978
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1 in the pre-IPO sequence.
2019-08-20 · 0001193125-19-225338
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS in the pre-IPO sequence.
2019-07-31 · 0001193125-19-207247
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 424B4 filing.
2019-07-29 · 0001193125-19-204654
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2019-07-24 · 0001193125-19-200564
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2019-06-07 · 0001193125-19-168278
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows FWP in the pre-IPO sequence.
261,637,146 shares
Common Stock · Exchange NASDAQ · Ticker VERO · Use of proceeds To facilitate the merger and related transactions · Flags foreign_private_issuer
2019-06-07 · 0001193125-19-167573
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2019-03-20 · 0001193125-19-079838
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2019-03-15 · 0001193125-19-076804
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2019-03-15 · 0001193125-19-076802
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1 in the pre-IPO sequence.
2019-03-15 · 0001193125-19-076799
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS/A in the pre-IPO sequence.
2019-03-15 · 0001193125-19-076795
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS in the pre-IPO sequence.
2019-03-15 · 0001193125-19-076787
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2019-03-15 · 0001193125-19-075571
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2018-12-10 · 9999999995-18-003084
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $1.50 · 10,000,000 shares · Gross proceeds $15,000,000
Common Stock · Exchange Nasdaq · Ticker HAIR · Over-allotment 1,500,000 · Underwriters William Blair, National Securities Corporation, Roth Capital Partners
2018-08-13 · 0001193125-18-247351
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2018-08-09 · 9999999995-18-002066
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2018-08-08 · 9999999995-18-002050
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2018-08-06 · 0001193125-18-238988
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
2018-07-06 · 0000950123-18-006624
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2017-10-13 · 0001193125-17-309983
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2017-10-11 · 9999999995-17-002638
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows FWP and registers the class of securities for exchange listing.
Restoration Robotics, Inc. filed Form 8-A12B to register its common stock on NASDAQ, referencing its S-1 registration statement and prospectus. This filing incorporates by reference the preliminary prospectus and financial disclosures from the earlier Free Writing Prospectus (FWP), which provided operational and financial estimates for Q3 2017 and historical performance trends.
2017-10-10 · 0001193125-17-306628
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Restoration Robotics, Inc. is a medical technology company offering the ARTAS System, a robotic device for follicular unit extraction hair restoration procedures. The company is conducting an IPO to raise capital, with shares priced between $7.00 and $9.00. The ARTAS System is FDA-cleared and marketed globally, with a focus on addressing limitations of traditional hair restoration methods. The offering includes underwriters National Securities Corporation, Roth Capital Partners, and Craig-Hallum Capital Group.
2017-10-06 · 0001193125-17-305963
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
Venus Concept Inc. (Restoration Robotics, Inc.) filed a Free Writing Prospectus (FWP) on October 6, 2017, supplementing its preliminary prospectus for an upcoming IPO. The filing includes preliminary Q3 2017 financial results, showing revenue growth, improved gross margins, and operational efficiency gains. It highlights seasonal challenges, including hurricane and earthquake impacts, and details revenue composition from system sales, procedure-based fees, and service-related activities. The company emphasizes efforts to boost physician adoption and system utilization to drive procedure-based revenue growth.
2017-10-06 · 0001193125-17-305032
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Exchange NASDAQ · Warrants to purchase Series C preferred stock · Flags warrants
Restoration Robotics, Inc. is conducting an initial public offering (IPO) for its common stock, with an expected price range of $7.00 to $9.00 per share. The company develops the ARTAS System, a robotic device for hair restoration procedures. The filing includes amendments to exhibits, re-filing of certain documents, and details about underwriting agreements, legal indemnifications, and recent unregistered securities sales. The company is an emerging growth company with reduced reporting requirements.
2017-09-22 · 0001193125-17-291521
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Venus Concept Inc. (formerly Restoration Robotics, Inc.) is conducting an initial public offering (IPO) to raise capital through the sale of 3,125,000 shares of common stock at an expected price range of $7.00 to $9.00 per share. The company develops and commercializes the ARTAS System, a robotic device for hair restoration procedures. The offering includes an underwriters' option to purchase additional shares. The company operates in a growing hair restoration market but faces risks related to competition, regulatory compliance, and reliance on its proprietary technology.
2017-09-18 · 0001193125-17-286792
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Restoration Robotics, Inc. is conducting an initial public offering (IPO) to raise capital through the sale of common stock. The company develops the ARTAS System, a robotic device for hair restoration procedures, which received FDA clearance in 2011. The offering includes a proposed maximum aggregate offering price of $28.75 million, with underwriters including National Securities Corporation, Roth Capital Partners, and Craig-Hallum Capital Group. The company aims to list on NASDAQ under the symbol 'HAIR' and highlights its proprietary technology, market expansion, and intellectual property protections.
2017-09-01 · 0001193125-17-275553
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Restoration Robotics, Inc. is conducting an initial public offering (IPO) to sell common stock, aiming to list on NASDAQ under the symbol 'HAIR'. The company develops the ARTAS System, a robotic device for hair restoration procedures, with FDA clearance since 2011. The filing highlights growth in international sales, patent protections, and the company's status as an emerging growth company with reduced reporting requirements. The IPO seeks to raise capital for expansion and operational needs.
2017-08-15 · 0000950123-17-008097
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Restoration Robotics, Inc. is preparing for its initial public offering (IPO) of common stock, aiming to list on NASDAQ under the symbol 'HAIR'. The company develops the ARTAS System, a robotic device for hair restoration procedures, and has received FDA clearance for its technology. The offering includes shares with an estimated price range, and the company expects to use proceeds for growth, marketing, and operational needs. The filing highlights risks related to reliance on the ARTAS System, regulatory challenges, and market competition.
2017-07-07 · 0000950123-17-005954
Comparable Deals

5 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 5 using nearest neighbors.
+29.4%
Median day-1
60%
Above issue
+42.8%
Median week-1
-21.7%
Downside (p10)
Mobia Medical, Inc. MOBI
2026-05-08 $140M Day 1: -21.7% Wk 1: -19.7%
same SICrecent IPO
MiniMed Group, Inc. MMED
2026-03-06 $560M Day 1: -7.6% Wk 1: -17.3%
same SICrecent IPO
SpyGlass Pharma, Inc. SGP
2026-02-06 $150M Day 1: +65.0% Wk 1: +71.9%
same SICrecent IPO
Alamar Biosciences, Inc. ALMR
2026-04-17 $191M Day 1: +29.4% Wk 1: +42.8%
same SIC grouprecent IPO
Ceribell, Inc. CBLL
2024-10-11 $180M Day 1: +47.1% Wk 1: +55.9%
same SIC groupolder IPO

Recent News

No recent news stored for this issuer.